Literature DB >> 14978279

Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring.

Wei Yang1, Motomu Shimaoka, Azucena Salas, Junichi Takagi, Timothy A Springer.   

Abstract

The function of some multidomain proteins is regulated by interdomain communication. We use second-site suppressor cysteine mutations to test a hypothesis on how the inserted (I)-like domain in the integrin beta-subunit regulates ligand binding by the neighboring I domain in the integrin alpha-subunit [Huth, J. R., Olejniczak, E. T., Mendoza, R., Liang, H., Harris, E. A., et al. (2000) Proc. Natl. Acad. Sci. USA 97, 5231-5236; and Alonso, J. L., Essafi, M., Xiong, J. P., Stehle, T. & Arnaout, M. A. (2002) Curr. Biol. 12, R340-R342]. The hypothesis is that an interaction between the beta I-like metal ion-dependent adhesion site (MIDAS) and an intrinsic ligand in the linker following the alpha I domain, Glu-310, exerts a pull that activates the alpha I domain. Individual mutation of alpha(L) linker residue Glu-310 or beta(2) MIDAS residues Ala-210 or Tyr-115 to cysteine abolishes I domain activation, whereas the double mutation of alpha(L)-E310C with either beta(2)-A210C or beta(2)-Y115C forms a disulfide bond that constitutively activates ligand binding. The disulfide-bonded mutant is resistant to small molecule antagonists that bind to the beta I-like domain near its interface with the alpha I domain and inhibit communication between these domains but remains susceptible to small molecule antagonists that bind underneath the I domain alpha 7-helix and certain allosteric antagonistic antibodies. Thus, the alpha 7-helix and its linker are better modeled as a pull spring than a bell rope. The results suggest that alpha(L) residue Glu-310, which is universally conserved in all I domain-containing integrins, functions as an intrinsic ligand for the beta I-like domain, and that when integrins are activated, the beta I-like MIDAS binds to Glu-310, pulls the spring, and thereby activates the alpha I domain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978279      PMCID: PMC365718          DOI: 10.1073/pnas.0307340101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Locking in alternate conformations of the integrin alphaLbeta2 I domain with disulfide bonds reveals functional relationships among integrin domains.

Authors:  C Lu; M Shimaoka; Q Zang; J Takagi; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

2.  Computational design of an integrin I domain stabilized in the open high affinity conformation.

Authors:  M Shimaoka; J M Shifman; H Jing; J Takagi; S L Mayo; T A Springer
Journal:  Nat Struct Biol       Date:  2000-08

3.  Cellular activation of leukocyte function-associated antigen-1 and its affinity are regulated at the I domain allosteric site.

Authors:  M L Lupher; E A Harris; C R Beals; L M Sui; R C Liddington; D E Staunton
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 4.  Integrin structure.

Authors:  M J Humphries
Journal:  Biochem Soc Trans       Date:  2000       Impact factor: 5.407

5.  Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin alphaL I domains with high affinity and antagonist activity in vivo.

Authors:  M Shimaoka; C Lu; R T Palframan; U H von Andrian; A McCormack; J Takagi; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

6.  Epitope mapping of antibodies to the C-terminal region of the integrin beta 2 subunit reveals regions that become exposed upon receptor activation.

Authors:  C Lu; M Ferzly; J Takagi; T A Springer
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

7.  NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.

Authors:  J R Huth; E T Olejniczak; R Mendoza; H Liang; E A Harris; M L Lupher; A E Wilson; S W Fesik; D E Staunton
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

8.  An isolated, surface-expressed I domain of the integrin alphaLbeta2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond.

Authors:  C Lu; M Shimaoka; M Ferzly; C Oxvig; J Takagi; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

9.  Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site.

Authors:  G Weitz-Schmidt; K Welzenbach; V Brinkmann; T Kamata; J Kallen; C Bruns; S Cottens; Y Takada; U Hommel
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

10.  Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation.

Authors:  Natalia Beglova; Stephen C Blacklow; Junichi Takagi; Timothy A Springer
Journal:  Nat Struct Biol       Date:  2002-04
View more
  37 in total

1.  Identification of integrin beta subunit mutations that alter heterodimer function in situ.

Authors:  Alison L Jannuzi; Thomas A Bunch; Robert F West; Danny L Brower
Journal:  Mol Biol Cell       Date:  2004-06-11       Impact factor: 4.138

2.  Structure of collagen receptor integrin α(1)I domain carrying the activating mutation E317A.

Authors:  Matti Lahti; Eva Bligt; Henri Niskanen; Vimal Parkash; Anna-Maria Brandt; Johanna Jokinen; Pekka Patrikainen; Jarmo Käpylä; Jyrki Heino; Tiina A Salminen
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

3.  The C-terminal αI domain linker as a critical structural element in the conformational activation of αI integrins.

Authors:  Gabriele Weitz-Schmidt; Thomas Schürpf; Timothy A Springer
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

Review 4.  The regulation of integrin function by divalent cations.

Authors:  Kun Zhang; JianFeng Chen
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

Review 5.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

Review 6.  Integrin structures and conformational signaling.

Authors:  Bing-Hao Luo; Timothy A Springer
Journal:  Curr Opin Cell Biol       Date:  2006-08-14       Impact factor: 8.382

Review 7.  Structural basis of integrin regulation and signaling.

Authors:  Bing-Hao Luo; Christopher V Carman; Timothy A Springer
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

8.  Regulation of outside-in signaling and affinity by the beta2 I domain of integrin alphaLbeta2.

Authors:  JianFeng Chen; Wei Yang; Minsoo Kim; Christopher V Carman; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-18       Impact factor: 11.205

Review 9.  Redox-relevant aspects of the extracellular matrix and its cellular contacts via integrins.

Authors:  Johannes A Eble; Flávia Figueiredo de Rezende
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

10.  Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism.

Authors:  Meredith W Miller; Sandeep Basra; Daniel W Kulp; Paul C Billings; Sungwook Choi; Mary Pat Beavers; Owen J T McCarty; Zhiying Zou; Mark L Kahn; Joel S Bennett; William F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.